Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Polish
  • Ukrainian

Breadcrumb

  1. Home
  2. Women and their microbiota
  3. Expert interview : Pr. Laurence Zitvogel
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • News
    • Thematics folders
    • Thematic pages
    • Microbiota Q & A
    • Patients Stories
    • Experts' point of view
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Healthcare professionals section

Find here your dedicated section
Biocodex logo
The power of your gut
My microbiota as a woman
Our marvelous microbiota

Breadcrumb

  1. Home
  2. Women and their microbiota
  3. Expert interview : Pr. Laurence Zitvogel
My microbiota as a woman

Expert interview : Pr. Laurence Zitvogel

Women health
The vaginal microbiota

Professor Laurence Zitvogel is Head of the Laboratory of Tumor Immunology and Cancer Immunotherapy, a joint research center (Inserm, Gustave Roussy, University Paris-South). Along with her team, she discovered that the efficacy of cancer therapies is influenced by the microbiota.

The power of your gut
My microbiota as a woman
Our marvelous microbiota
  • Learn all about microbiota
    • The gut microbiota
    • The ENT microbiota
    • The pulmonary microbiota
    • The urinary microbiota
    • The skin microbiota
    • The vaginal microbiota
  • Microbiota and related conditions
    • Digestive disorders
    • Women disorders
    • Metabolic disorders
    • Skin disorders
    • Pediatric disorders
    • Psychiatric disorders
    • Neurological disorders
    • Respiratory disorders
    • Urinary disorders
  • Act on your microbiota
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplant
    • Diet
  • Publications
    • News
    • Thematics folders
    • Thematic pages
    • Microbiota Q & A
    • Patients Stories
    • Experts' point of view
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Healthcare professionals section

Find here your dedicated section
Biocodex logo

Sources

This article is based on scientific information

Sharing is caring

Your friends might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

About this article

Created 09 October 2019
Updated 03 January 2022
Image
Femmes-parole-expert-image1

Through which mechanisms does the microbiota influence the efficacy of chemotherapy or immunotherapy?

We have shown that chemotherapy leads to intestinal permeability, which facilitates the spread of bacteria into the immune system. Although this downside is the source of many adverse events (nausea, diarrhea, vomiting), it is also paradoxically very useful since it stimulates the immune system and boosts the effect of the antitumor drug.

As for immunotherapy, its aim is to mobilize the immune system against tumors, and its success also seems to depend on the intestinal microbiota which acts on three main mechanisms:

  • Its composition impacts the distribution of lymphocytes (white blood cells) in the digestive tube, and thus impacts the endogenous defense system, as was recently shown in several articles.
  • Some of its metabolites could activate the immune system, although it has yet to be demonstrated.
  • It activates mechanisms of intestinal barrier repair which contribute to treatment efficacy.

How are these findings going to change the management of cancers treated by chemotherapy or immunotherapy?

Probiotics used as complement to the existing therapeutic arsenal (surgery, radiotherapy, chemotherapy, hormone therapy, immunotherapy) could become a sixth therapeutic modality against cancer. When there is no infection, we will avoid prescribing prophylactic antibiotics (preventive treatment), while in case of infection, we will postpone immunotherapy. Our objective is to identify patients with an intestinal dysbiosis and to restore their microbiota before starting immunotherapy or chemotherapy.

What are the research avenues currently considered to modulate the composition of the intestinal microbiota?

Probiotics administration and fecal transplant (transplant of the microbiota from a healthy individual into the patient’s digestive tract) are the main avenues under investigation to restore a microbiota which is likely to hinder treatment. These bacteria, called “oncomicrobiotics” are not intended to increase the efficacy of chemotherapy or immunotherapy on their own. Their aim is to prepare the organism of a patient with dysbiosis to respond positively to these immunomodulating treatments. More and more biotechnology companies dedicate part of their research efforts to the development of “anticancer” probiotics. However, only multidisciplinary research followed by large-scale clinical trials will be able to identify which are the “friendly” bacteria and to assess their efficacy within the context of chemotherapy or immunotherapy. We can expect progress in the foreseeable future.

Tags
Cancer Microbiome Flora

    See also

    Actu GP : Endométriose : le microbiote vaginal comme outil prédictif de sévérité ? Can the vaginal microbiota be used as a tool for predicting the severity of endometriosis?
    Actu GP : Vaginose bactérienne : bientôt une greffe de microbiote vaginal ? Bacterial vaginosis: could there soon be a vaginal microbiota transplant ?
    Focus
    Women and their microbiota
    • Microbiota, vulvovaginal infections and cystitis
      • Is bacterial vaginosis a disease?
      • Escherichia coli or the influence of intestinal microbiota on urinary tract infections
      • Are certain women predisposed to STIs?
    • Reproductive health, pregnancy and postpartum
      • Role of the vaginal microbiota in the health of the reproductive system and that of future generations
      • Cervical microbiome in postpartum HIV-positive women
    • After menopause
      • Natural remedies against osteoporosis?
      • Oral and intestinal microbiota: towards a different management of menopause
    • Microbiota and cancer
      • Microbiota and breast cancer
      • Expert interview : Pr. Laurence Zitvogel
    Created 09 October 2019
    Updated 03 January 2022

    About this article

    To know more about this topic.

    Main topic

    Women health

    Related microbiotas

    The vaginal microbiota
    Microbiota and breast cancer
    Focus

    Women and their microbiota

    Microbiota, vulvovaginal infections and cystitis

    Is bacterial vaginosis a disease? Escherichia coli or the influence of intestinal microbiota on urinary tract infections Are certain women predisposed to STIs?

    Reproductive health, pregnancy and postpartum

    Role of the vaginal microbiota in the health of the reproductive system and that of future generations Cervical microbiome in postpartum HIV-positive women

    After menopause

    Natural remedies against osteoporosis? Oral and intestinal microbiota: towards a different management of menopause

    Microbiota and cancer

    Microbiota and breast cancer Expert interview : Pr. Laurence Zitvogel
    My microbiota as a woman
    Allergies : et si tout venait du microbiote ?
    28.03.2023

    Allergies: and what if it all started with the microbiota?

    Read the article

    Microbiotalk : short conferences on antimicrobial resistance

    Breaking the silence: a global conversation on antimicrobial resistance Antimicrobial resistance (AM...

    Find out more
    Photo LP: Infertilité : des bactéries et des virus vaginaux co-impliqués
    01.04.2025

    Infertility: vaginal bacteria and viruses both implicated

    Read the article
    11.05.2021

    Dust microbiota from the city or the countryside? Atopic dermatitis has a preference!

    Read the article
    Actu GP : Vaginose bactérienne : les hommes seraient-ils impliqués ?
    24.11.2020

    Are men involved in bacterial vaginosis?

    Read the article
    30.12.2024

    Female anatomy, microbiotas and intimate hygiene

    Read the article
    Periods & vaginal microbiota: Science in progress…
    11.01.2023

    Periods & vaginal microbiota: Science in progress…

    Read the article

    The vaginal microbiota

    The vaginal microbiota: how to take care of it? Hundreds of bacteria populate the vagina.1 Let’s see...

    Find out more
    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo
    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota
    • English
    • Français
    • Español
    • Russian
    • Polish
    • Ukrainian

    Browse the site

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Healthcare professionals section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the microbiota community and receive "The Essentials" once a month to stay up to date with the latest news on the microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    13.05.2025

    When sodas harm your microbiota and your health

    Read the article
    07.05.2025

    Downside of fruit and vegetable juices for gut health

    Read the article
    Photo LP: Sensibles à l’E466 ? Votre microbiote a son mot à dire
    15.04.2025

    Sensitive to E466? Your microbiota plays a role

    Read the article

    Stay updated

    Join the Microbiota Community and receive once a month “The Essential” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Learn all about microbiota
      • The gut microbiota
      • The ENT microbiota
      • The pulmonary microbiota
      • The urinary microbiota
      • The skin microbiota
      • The vaginal microbiota
    • Microbiota and related conditions
      • Digestive disorders
      • Women disorders
      • Metabolic disorders
      • Skin disorders
      • Pediatric disorders
      • Psychiatric disorders
      • Neurological disorders
      • Respiratory disorders
      • Urinary disorders
    • Act on your microbiota
      • Probiotics
      • Prebiotics
      • Fecal Microbiota Transplant
      • Diet
    • Publications
      • News
      • Thematics folders
      • Thematic pages
      • Microbiota Q & A
      • Patients Stories
      • Experts' point of view
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Healthcare professionals section

    Find here your dedicated section
    Biocodex logo

    Discover

    The power of your gut
    My microbiota as a woman
    Our marvelous microbiota

    Healthcare professionals section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo